Ikarian Capital’s Pardes Biosciences PRDS Stock Holding History
Bought
Maintained
Sold
Other funds holding PRDS
VS
LCM
Ikarian Capital's PRDS Position: Q3 2022 in Review
Ikarian Capital sold out of Pardes Biosciences (PRDS) in Q3 2022, closing a stake of 223,934 shares — an estimated $687K sold.
Ikarian Capital first reported a position in PRDS in Q4 2021 and held it in 3 quarters. The position peaked at $6.55M in Q4 2021. 68 funds tracked by Wall St. Rank hold PRDS as of Q3 2022.
- Ikarian Capital reported no remaining Pardes Biosciences position as of Q3 2022 after selling out during the quarter.
- Ikarian Capital sold 223,934 Pardes Biosciences shares in Q3 2022, an estimated $687K.
- Ikarian Capital first reported a position in Pardes Biosciences in Q4 2021 and held it in 3 quarters.
- Ikarian Capital's Pardes Biosciences position peaked at $6.55M in Q4 2021.
- 68 funds tracked by Wall St. Rank held Pardes Biosciences as of Q3 2022.
Based on Ikarian Capital's 13F filing for Q3 2022, filed 14 Nov 2022.